Picture of Rainmed Medical logo

2297 Rainmed Medical Share Price

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m-29.12%
3m-55.9%
6m-77.81%
1yr-87.24%
Volume Change (%)
10d/3m-16.06%
Price vs... (%)
52w High-87.25%
50d MA-25.77%
200d MA-70.07%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-24.08%
Return on Equity-20.43%
Operating Margin-175.07%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Rainmed Medical EPS forecast chart

Profile Summary

Rainmed Medical Ltd is a China-based investment holding company. The Company is primarily engaged in research and development, manufacturing and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) system and coronary angiography-derived index of microvascular resistance (caIMR) system. The Company’s core products, caFFR system and caIMR system, are innovative medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). They are designed to eliminate the usage of pressure wires, significantly reduce the risk of technical errors and operation time, and improve physiological assessment. The Company mainly operates its businesses in the domestic and overseas markets.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    August 1st, 2014
    Public Since
    July 8th, 2022
    No. of Employees
    406
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    hk flag iconStock Exchange of Hong Kong Limited
    Shares in Issue
    1,167,799,000
    Blurred out image of a map
    Address
    SUZHOU, 215000
    Web
    https://www.rainmed.com/
    Phone
    Auditors
    PricewaterhouseCoopers

    2297 Share Price Performance

    Upcoming Events for 2297

    Similar to 2297

    Picture of Acotec Scientific Holdings logo

    Acotec Scientific Holdings

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Beijing Airdoc Technology Co logo

    Beijing Airdoc Technology Co

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of AK Medical Holdings logo

    AK Medical Holdings

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of AMCO United Holding logo

    AMCO United Holding

    hk flag iconStock Exchange of Hong Kong Limited

    Picture of Angelalign Technology logo

    Angelalign Technology

    hk flag iconStock Exchange of Hong Kong Limited

    FAQ